Crossmark

Lycium barbarum glycopeptide mitigates retinal ischemia-reperfusion injury through its anti-inflammatory, anti- senescence, and anti-apoptosis properties

Crossref DOI link: https://doi.org/10.1038/s41598-025-10763-y

Published Online: 2025-07-30

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Zhao, Chunlin

Lu, Xuejing

Zhao, Yanxia

Shi, Wei
Funding

Funding for this research was provided by:

National Natural Science Foundation of China (8217444, 82401826)

Natural Science Foundation of the Jiangsu Higher Education Institutions of China (24KJB320012)

Jiangsu Provincial Hospital of Chinese Medicine Outstanding Young Doctor Program (2024QB039)
License Information

Text and Data Mining valid from 2025-07-30

Version of Record valid from 2025-07-30
More Information

Article History

Received: 26 February 2025

Accepted: 7 July 2025

First Online: 30 July 2025

Declarations

:

: The authors declare no competing interests.

: All methods were carried out in accordance with relevant guidelines and regulations.

Document is current

Any future updates will be listed below